Table 2. Changes in nutritional status associated with BAY 41–2272 treatment in guinea pigs chronically exposed to CS.
| Mean ± SD | 2-way ANOVA | ||||||
|---|---|---|---|---|---|---|---|
| Sham + Vehicle |
Sham + BAY 41–2272 |
CS + Vehicle |
CS + BAY 41–2272 |
Effect of CS | Effect of BAY 41–2272 | Interaction between CS & BAY 41–2272 | |
| Protein (g/L) | 41 ± 5 | 45 ± 2 | 43 ± 4 | 46 ± 4 | 0.37 | 0.03 | 0.91 |
| Triglyceride (mg/dL) | 185 ± 80 | 157 ± 31 | 159 ± 90 | 187 ± 105 | 0.69 | 0.97 | 0.49 |
| Cholesterol (mg/dL) | 42 ± 18 | 42 ± 7 | 44 ± 18 | 43 ± 13 | 0.79 | 0.91 | 0.82 |
Representation of the mean ± SD in the different experimental groups. Statistical differences were analyzed by 2-way ANOVA. Effects of CS exposure, BAY 41–2272 treatment, and their interaction, respectively, are represented at the right of the table.